Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection Arjun Pennathur,

Slides:

Advertisements

Similar presentations

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Advertisements

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Preliminary results of anatomic lung resection using energy-based tissue and vessel coagulative fusion technology Matthew J. Schuchert, MD, Ghulam Abbas,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Roux-en-Y Near Esophagojejunostomy for Failed Antireflux Operations: Outcomes in More Than 100 Patients Omar Awais, DO, James D. Luketich, MD, Neha Reddy,

Arjun Pennathur, MD, Andrew C. Chang, MD, Kevin M

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

William M. DeCampli, MD, PhD

Benefits of resection for metachronous lung cancer

How should we treat air leaks?

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Roux-en-Y Near Esophagojejunostomy for Intractable Gastroesophageal Reflux After Antireflux Surgery Omar Awais, DO, James D. Luketich, MD, John Tam,

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Video-Assisted Thoracic Surgery Thymectomy Versus Sternotomy Thymectomy in Patients With Thymoma Hiroyuki Agatsuma, MD, Kazuo Yoshida, MD, PhD, Ichiro.

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

VATS Thymectomy with 3D Vision: A Chance to Further Improve the Outcomes of Thymus Minimally Invasive Surgery Federico Attene, MD, Fabrizio Scognamillo,

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma Paul C. Lee, MD, Farooq M. Mirza, MD, Jeffrey.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Minimally invasive resection of benign esophageal tumors

Minimally invasive tricuspid valve surgery in patients at high risk

Replicating the success of mitral valve repair in the aortic valve

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Electromagnetic Navigation Bronchoscopy-Guided Dye Marking for Thoracoscopic Resection of Pulmonary Nodules Omar Awais, DO, Michael R. Reidy, MD, Kunal.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

James I. Fann, MD, John E. Connolly, MD

Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes

Jason J. Han, MD, Pavan Atluri, MD

First nights, the adrenal axis, and steroids

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Todd L. Demmy, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease Takeshi Kinoshita, MD, PhD, Tohru Asai, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Stage III thymoma: Relationship of local invasion to recurrence

Matthew J. Schuchert, MD, André P

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

The future of cardiac surgery training: A survival guide

Benny Weksler, MD, Manisha Shende, MD, Katie S

Hope should not spring eternal

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

Postoperative medication management after surgical ablation: Clarifying the role of amiodarone therapy Hersh Maniar, MD, Eric Novak, MS The Journal.

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Omar Awais, DO, James D. Luketich, MD, Matthew J

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Junaid Haroon, MD, Subroto Paul, MD, MPH

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Matthew J. Schuchert, MD, Brian L

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for.

Sebastien Gilbert, MD, David O. Wilson, MD, MPH, Neil A

Presentation transcript:

Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection Arjun Pennathur, MD, Irfan Qureshi, MD, Matthew J. Schuchert, MD, Rajeev Dhupar, MD, Peter F. Ferson, MD, William E. Gooding, MS, Neil A. Christie, MD, Sebastien Gilbert, MD, Manisha Shende, MD, Omar Awais, DO, Joel S. Greenberger, MD, Rodney J. Landreneau, MD, James D. Luketich, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 3, Pages 694-701 (March 2011) DOI: 10.1016/j.jtcvs.2010.09.003 Copyright © 2011 Terms and Conditions

Figure 1 Kaplan–Meier plot illustrating overall survival for entire group, with confidence limits. Time, in years, from thymectomy plotted on x-axis. Dotted lines indicate 95% confidence bands for probability of overall survival. Numbers at risk shown above x-axis. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 694-701DOI: (10.1016/j.jtcvs.2010.09.003) Copyright © 2011 Terms and Conditions

Figure 2 Kaplan–Meier plot illustrating recurrence-free survival for entire group, with confidence limits. Time, in years, from thymectomy plotted on x-axis. Dotted lines indicate 95% confidence bands for probability of recurrence-free survival. Numbers at risk shown above x-axis. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 694-701DOI: (10.1016/j.jtcvs.2010.09.003) Copyright © 2011 Terms and Conditions

Figure 3 A, Kaplan–Meier plot illustrating recurrence-free survival stratified by group (thoracoscopic vs open). Time, in years, from thymectomy plotted on x-axis. B, Kaplan–Meier plot illustrating recurrence-free survival for patients with stage I thymoma stratified by group (thoracoscopic vs open). Time, in years, from thymectomy plotted on x-axis. Numbers at risk shown above x-axis. C, Kaplan–Meier plot illustrating recurrence-free survival for patients with stage II thymoma stratified by group (thoracoscopic vs open). Time, in years, from thymectomy plotted on x-axis. Numbers at risk shown above x-axis. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 694-701DOI: (10.1016/j.jtcvs.2010.09.003) Copyright © 2011 Terms and Conditions